Gregory D. Gorgas Net Worth

The estimated Net Worth of Gregory D. Gorgas is at least $634 millier dollars as of 12 August 2022. Mr Gorgas owns over 1,200 units of Artelo Biosciences Inc stock worth over $2,856 and over the last 5 years he sold ARTL stock worth over $0. In addition, he makes $631,539 as Pres, CEO, CFO, Treasurer et Sec. & Director at Artelo Biosciences Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr Gorgas ARTL stock SEC Form 4 insiders trading

Mr has made over 9 trades of the Artelo Biosciences Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he bought 1,200 units of ARTL stock worth $4,800 on 12 August 2022.

The largest trade he's ever made was buying 8,500 units of Artelo Biosciences Inc stock on 16 April 2021 worth over $9,775. On average, Mr trades about 2,160 units every 65 days since 2019. As of 12 August 2022 he still owns at least 2,400 units of Artelo Biosciences Inc stock.

You can see the complete history of Mr Gorgas stock trades at the bottom of the page.

Mr. Gregory D. Gorgas biography

Gregory D. Gorgas is the Pres, CEO, CFO, Treasurer, Sec. & Director at Artelo Biosciences Inc.

What is the salary of Mr Gorgas?

As the Pres, CEO, CFO, Treasurer et Sec. & Director of Artelo Biosciences Inc, the total compensation of Mr Gorgas at Artelo Biosciences Inc is $631,539. There are no executives at Artelo Biosciences Inc getting paid more.

How old is Mr Gorgas?

Mr Gorgas is 58, he's been the Pres, CEO, CFO, Treasurer et Sec. & Director of Artelo Biosciences Inc since . There are 1 older and 2 younger executives at Artelo Biosciences Inc. The oldest executive at Artelo Biosciences Inc is Dr. Steven D. Reich, 75, who is the Chief Medical Officer.

What's Mr Gorgas's mailing address?

Gregory's mailing address filed with the SEC is 505 LOMAS SANTA FE, SUITE 160, , SOLANA BEACH, CA, 92075.

Insiders trading at Artelo Biosciences Inc

Over the last 22 years, insiders at Artelo Biosciences Inc have traded over $1,017,062 worth of Artelo Biosciences Inc stock and bought 94,621 units worth $215,565 . The most active insiders traders include Connie Matsui, Steven B Lapin et Georgia Erbez. On average, Artelo Biosciences Inc executives and independent directors trade stock every 89 days with the average trade being worth of $13,026. The most recent stock trade was executed by Gregory D. Gorgas on 12 August 2022, trading 1,200 units of ARTL stock currently worth $4,800.

What does Artelo Biosciences Inc do?

artelo biosciences is a biopharmaceutical company dedicated to applying true biopharma discipline in leveraging past research and leading-edge, world-class science to accelerate the development and commercialization of a diverse portfolio of novel, endocannabinoid system modulating therapeutics. our programs have the potential to dramatically improve patient care in major markets. with our headquarters team in san diego, california, usa and our european office in dublin, ireland, artelo established a presence in key global biopharma innovation hubs with close access to world-class research expertise. artelo’s research and development leverages the skill, knowledge and experience of our collaboration partners in europe and north america.

Complete history of Mr Gorgas stock trades at Artelo Biosciences Inc

Artelo Biosciences Inc executives and stock owners

Artelo Biosciences Inc executives and other stock owners filed with the SEC include:

• Gregory D. Gorgas,
  Pres, CEO, CFO, Treasurer, Sec. & Director
• Jason H. Baybutt,
  Sr. VP of Fin.
• Dr. Steven D. Reich,
  Chief Medical Officer
• Peter Michael O'Brien,
  Sr. VP of European Operations
• Dr. Andrew Yates Ph.D.,
  Sr. VP, Chief Scientific Officer & Member of Scientific Advisor Board
• Randy Schreckhise,
  VP of Fin. & Operations
• Donald T Netter,
  Director
• Brian Schlier,
  Vice President
• James G Tatum,
  Director
• John A Whritner,
  Director
• John L Lahey,
  Director
• Ira R Harkavy,
  Director
• Inc. Lrta,,
  10% owner
• Corp /De/Nasco Holdings, In...,
  
• Steven B Lapin,
  President & COO
• H William Smith,
  V.P., Gen. Counsel & Secretary
• W Phillip Niemeyer,
  Vice President-Prod. Coord.
• Dean T Johnson,
  Chief Financial Officer
• Corp /De/ Geneve,
  10% owner
• John Joseph Crawford,
  Director
• Sharon M Oster,
  Director
• Douglas Blayney,
  Director
• Connie Matsui,
  Director
• Peter Michael O'brien,
  
• Steven Kelly,
  Director
• John W Beck,
  
• Georgia Erbez,
  
• Robert Martin Emanuele,
  Director
• Gregory Reyes,
  Director
• Tamara A Favorito,
  Director
• Gregory D. Gorgas,
  Pres, CEO, CFO, Treas & Sec